Paper42860554PubMed
Haematopoietic Cells Deficient for Calreticulin or Expressing Its Oncogenic Variants Maintain Functional Antigen Presentation.
Höhrhan M and 8 others. J Cell Mol Med, 2026.
Cite this record
ConductScience Library. Haematopoietic Cells Deficient for Calreticulin or Expressing Its Oncogenic Variants Maintain Functional Antigen Presentation. Papers, record 42860554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42860554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Haematopoietic Cells Deficient for Calreticulin or Expressing Its Oncogenic Variants Maintain Functional Antigen Presentation.
- Journal
- J Cell Mol Med
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-14
Source PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calreticulin | Major topic |
| Antigen Presentation | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Histocompatibility Antigens Class I | |
| Mutation | |
| Receptors, Thrombopoietin | |
| T-Lymphocytes |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P34451-B | Austrian Science Fund | PubMed | ||
| P35806-B | Austrian Science Fund | PubMed | ||
| P36646-B | Austrian Science Fund | PubMed | ||
| 10102897 | HORIZON EUROPE Marie Sklodowska-Curie Actions | PubMed |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27013444 | Homozygous calreticulin mutations in patients with myelofibrosis lead to acquired myeloperoxidase deficiency. | Blood | 2016 | https://conductscience.org/library/papers/27013444 | PubMed |
| 2 | 19182777 | Complete but curtailed T-cell response to very low-affinity antigen. | Nature | 2009 | https://conductscience.org/library/papers/19182777 | PubMed |
| 3 | 31064751 | Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms. | Blood | 2019 | https://conductscience.org/library/papers/31064751 | PubMed |
| 4 | 19851281 | Calreticulin-dependent recycling in the early secretory pathway mediates optimal peptide loading of MHC class I molecules. | EMBO J | 2009 | https://conductscience.org/library/papers/19851281 | PubMed |
| 5 | 10777614 | Functional relationship between calreticulin, calnexin, and the endoplasmic reticulum luminal domain of calnexin. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10777614 | PubMed |
| 6 | 11152613 | Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. | J Mol Biol | 2001 | https://conductscience.org/library/papers/11152613 | PubMed |
| 7 | 12434335 | VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages. | Genesis | 2002 | https://conductscience.org/library/papers/12434335 | PubMed |
| 8 | 19748124 | Calreticulin maintains the low threshold of peptide required for efficient antigen presentation. | Mol Immunol | 2009 | https://conductscience.org/library/papers/19748124 | PubMed |
| 9 | 2445888 | Site-directed mutagenesis of class I HLA genes. Role of glycosylation in surface expression and functional recognition. | J Exp Med | 1987 | https://conductscience.org/library/papers/2445888 | PubMed |
| 10 | 15226359 | Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. | J Exp Med | 2004 | https://conductscience.org/library/papers/15226359 | PubMed |
| 11 | 33761144 | Hematopoietic expression of a chimeric murine-human CALR oncoprotein allows the assessment of anti-CALR antibody immunotherapies in vivo. | Am J Hematol | 2021 | https://conductscience.org/library/papers/33761144 | PubMed |
| 12 | 34390367 | Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells. | Ann Hematol | 2021 | https://conductscience.org/library/papers/34390367 | PubMed |
| 13 | 4272851 | Isolation of a high affinity calcium-binding protein from sarcoplasmic reticulum. | J Biol Chem | 1974 | https://conductscience.org/library/papers/4272851 | PubMed |
| 14 | 17947644 | Molecular architecture of the TAP-associated MHC class I peptide-loading complex. | J Immunol | 2007 | https://conductscience.org/library/papers/17947644 | PubMed |
| 15 | 16492806 | Regulation of peripheral T cell activation by calreticulin. | J Exp Med | 2006 | https://conductscience.org/library/papers/16492806 | PubMed |
| 16 | 23302045 | Whole blood transcriptional profiling reveals significant down-regulation of human leukocyte antigen class I and II genes in essential thrombocythemia, polycythemia vera and myelofibrosis. | Leuk Lymphoma | 2013 | https://conductscience.org/library/papers/23302045 | PubMed |
| 17 | 22039305 | Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A viruses. | J Immunol | 2011 | https://conductscience.org/library/papers/22039305 | PubMed |
| 18 | 18228427 | Calcium phosphate transfection. | Curr Protoc Cell Biol | 2003 | https://conductscience.org/library/papers/18228427 | PubMed |
| 19 | 29107940 | Structure of the human MHC-I peptide-loading complex. | Nature | 2017 | https://conductscience.org/library/papers/29107940 | PubMed |
| 20 | 33202418 | Hematoxylin binds to mutant calreticulin and disrupts its abnormal interaction with thrombopoietin receptor. | Blood | 2021 | https://conductscience.org/library/papers/33202418 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42860554
GET https://conductscience.org/api/papers/v1/42860554/references?page=2